Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
01/20/2011 | CA2767372A1 3-phenoxymethylpyrrolidine compounds |
01/20/2011 | CA2767233A1 5-ht3 receptor modulators, methods of making, and use thereof |
01/20/2011 | CA2765921A1 Imidazole derivatives as mglur5 antagonists |
01/20/2011 | CA2764927A1 Exo-s-mecamylamine method, use, and compound for treatment |
01/19/2011 | EP2275557A1 Albumin fusion proteins |
01/19/2011 | EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
01/19/2011 | EP2275433A1 Metastin derivative and use thereof |
01/19/2011 | EP2275421A1 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction |
01/19/2011 | EP2275404A1 Homocysteine synthase inhibitor |
01/19/2011 | EP2275143A2 Conjugated anti-psychotic drugs and uses thereof |
01/19/2011 | EP2275129A2 Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins |
01/19/2011 | EP2275118A2 Pancreas-specific proteins |
01/19/2011 | EP2275117A1 GLP-1, exendin-4, peptide analogs and uses thereof |
01/19/2011 | EP2275110A2 Cladribine regimen for treating Multiple Sclerosis |
01/19/2011 | EP2275109A2 Pregnane steroids for use in the treatment of CNS disorders |
01/19/2011 | EP2275105A1 Heterocyclic derivatives as opioid receptor modulators |
01/19/2011 | EP2275096A2 Neurogenesis via modulation of the muscarinic receptors |
01/19/2011 | EP2275095A2 Neurogenesis by muscarinic receptor modulation |
01/19/2011 | EP2275091A1 Pharmaceutical compositions comprising adsorbates of an amorphous drug |
01/19/2011 | EP2274317A1 Synthesis of timosaponin bii |
01/19/2011 | EP2274307A1 Bridged heterocyclic compounds and methods of use |
01/19/2011 | EP2274053A2 Use of the human pancreatic polypeptide as a therapeutic agent |
01/19/2011 | EP2274042A1 Treatment and/or prevention of multiple sclerosis |
01/19/2011 | EP2274016A2 Use of pegylated igf-i variants for the treatment of neuromuscular disorders |
01/19/2011 | EP2274011A2 An antibody bound synthetic vesicle containing active agent molecules |
01/19/2011 | EP2273993A1 Methods and compositions for the intracerebroventricular administration of felbamate |
01/19/2011 | EP2273991A1 3-hydroxy gepirone for the treatment of attention deficit disorder and sexual dysfunction |
01/19/2011 | EP2273882A1 Bioactive compounds for treatment of cancer and neurodegenerative diseases |
01/19/2011 | EP2142193B1 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition |
01/19/2011 | EP2117560B1 A composition for selective serotonin reuptake inhibition and process thereof |
01/19/2011 | EP2094685B1 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperdine derivatives as orexin receptor inhibitors |
01/19/2011 | EP2013209B1 Pyrazolo-tetrahydropyridine derivatives as orexin receptor antagonists |
01/19/2011 | EP2013179B1 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
01/19/2011 | EP1693456B1 Method of identifying modulators of a g protein-coupled receptor |
01/19/2011 | EP1670450B1 Pharmaceutical compositions and method of using levodopa and carbidopa |
01/19/2011 | EP1656375B1 Novel quinuclidine derivatives and their pharmaceutical use |
01/19/2011 | EP1481969B1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient |
01/19/2011 | EP1448995B1 Assay for screening candidate drugs for the treatment of inflammatory diseases |
01/19/2011 | EP1432416B1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
01/19/2011 | EP1330442B1 Phthalazinone derivatives |
01/19/2011 | EP1185296B1 Prevention and treatment of amyloidogenic diseases |
01/19/2011 | CN201709412U Health and massage bra pad containing cassia seeds |
01/19/2011 | CN1989117B Substituted benzothiazoles |
01/19/2011 | CN1977951B Gastrodia elata plant extract for preventing senile dementia and its preparing method |
01/19/2011 | CN1950389B Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
01/19/2011 | CN1938010B Novel use of peptide compounds for treating pain in painful diabetic neuropathy |
01/19/2011 | CN1929847B Fasudil-containing preparation and method of improving stability thereof |
01/19/2011 | CN101952291A 4-(9-(3, 3-difluorocyclopentyl) -5, 7, 7-trimethyl-6-oxo-6, 7, 8, 9-tetrahydro-5h-pyrimido [4, 5-B[1, 4] diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases PLK41 to PLK4 for the treatment of proliferative diseases |
01/19/2011 | CN101952284A New tetracyclic compounds |
01/19/2011 | CN101952280A Bicyclic heterocyclic derivative |
01/19/2011 | CN101952278A 3-alkyl-piperazine derivatives and uses thereof |
01/19/2011 | CN101952276A 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
01/19/2011 | CN101952275A Modulators for amyloid beta |
01/19/2011 | CN101952267A Cyclopropyl amine derivatives |
01/19/2011 | CN101952266A Compound (R) -N*6*-ethyl-6, 7-dihydro-5H-indeno (5, 6- d) thiazole-2, 6-diamine and the use as antipsychotics |
01/19/2011 | CN101952260A 4, 5-dihydro-oxazol-2-yl amine derivatives |
01/19/2011 | CN101952256A Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40 |
01/19/2011 | CN101952240A Process for preparing O-desmethylvenlafaxine |
01/19/2011 | CN101951935A Therapeutic agent for cerebral ischemic injury |
01/19/2011 | CN101951923A Liquid nucleotides/nucleosides-containing product |
01/19/2011 | CN101951908A Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy |
01/19/2011 | CN101951904A Benzothiazole and benzoxazole derivatives and methods of use |
01/19/2011 | CN101951897A Use of amidoxime carboxylic acid esters and N-hydroxyguanidine carboxylic acid esters for producing prodrugs |
01/19/2011 | CN101951790A A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent |
01/19/2011 | CN101948539A IL-18 binding proteins |
01/19/2011 | CN101948523A Artificial in-vitro preparation method of low molecular weight amyloid peptide oligomer and application |
01/19/2011 | CN101948464A 3,4,6-triaryl-(1,3)-oxazine-2-ketone compound as well as preparation method and application thereof |
01/19/2011 | CN101948462A Azaspiroalkene and azaspiroalkane compounds with nicotinic cholinergic receptor activity |
01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
01/19/2011 | CN101948416A Compound used for treating metabolic disorder |
01/19/2011 | CN101947306A Treatment of T-cell mediated diseases |
01/19/2011 | CN101947281A Chinese medicament for treating diabetic peripheral neuritis |
01/19/2011 | CN101947267A Solid fragrant anti-dizziness agent and preparation method thereof |
01/19/2011 | CN101947266A Solid aromatic sobering-up agent and preparation method thereof |
01/19/2011 | CN101947265A Application of Aleppo avens or compound preparations containing Aleppo avens in preparing drugs for treating cardiovascular and cerebrovascular system diseases |
01/19/2011 | CN101947263A Medicament for treating neurasthenia and insomnia |
01/19/2011 | CN101947255A Magnoliabiloba extract and extracting method thereof |
01/19/2011 | CN101947251A Method for preparing chickpea isoflavone microcapsules |
01/19/2011 | CN101947249A Method for ultrasonic extraction of total saponins of rhizoma panacis majoris |
01/19/2011 | CN101947242A Preparation method of deproteinized calf blood extract |
01/19/2011 | CN101947235A Medicamentous application of CPE (Conjugated Polyelectrolyte) |
01/19/2011 | CN101947221A New application of imatinib mesylate |
01/19/2011 | CN101947209A Divalproex sodium pellets and preparation method thereof |
01/19/2011 | CN101947205A Novel galanthamine sustained-release preparation and preparation method thereof |
01/19/2011 | CN101946986A Nanometer anion fabric seaman body-building working uniform with characteristics of ultra-oleophobic and ultra-hydrophilic properties, antifouling property and self-cleaning property |
01/19/2011 | CN101946985A Element fabric health-improving protective clothing capable of killing and repelling mosquitoes |
01/19/2011 | CN101669960B Akebiasaponin D and application of composition thereof in preparation of medicaments for treating senile dementia |
01/19/2011 | CN101647858B Preparation method of water-soluble extract of red sage root |
01/19/2011 | CN101560213B Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application |
01/19/2011 | CN101548969B Use of ethyl malonyl silybin derivant in preparing antioxidant medicine |
01/19/2011 | CN101485864B Chinese medicine for treating neurasthenia |
01/19/2011 | CN101439073B Application of Chinese medicinal composition in preparing medicament for preventing and treating dysmnesia and improving memory |
01/19/2011 | CN101386818B Extract of sea fungal culture and preparation method and application thereof |
01/19/2011 | CN101362731B Heterocyclic compounds and methods of use |
01/19/2011 | CN101258154B Pyrazolo [3,4-D]azepine derivatives as histamine H3 antagonists |
01/19/2011 | CN101254226B Duliang compound chinese medicine soft capsules |
01/19/2011 | CN101239981B Pyrazolo and imidazo-pyrimidine derivatives |
01/19/2011 | CN101239104B Kava piper methysticum extract and preparation method thereof |
01/19/2011 | CN101237885B Agent for regeneration and/or protection of nerves |
01/19/2011 | CN101185471B Tea capable of giving up smoking and preparation method thereof |